Aeolus Pharmaceuticals, Inc. (AOLS)

Market Cap	152.00 -99.0%
Revenue (ttm)	771.00K -68.7%
Net Income	-4.09M
EPS	-0.03
Shares Out	152.09M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	312,988
Open	0.0001
Previous Close	n/a
Day's Range	0.000001 - 0.0001
52-Week Range	0.000001 - 0.0001
Beta	-61.53
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Aeolus Pharmaceuticals

Aeolus Pharmaceuticals, Inc., a biopharmaceutical company, develops a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious, and central nervous system diseases in the United States. The company develops a class of catalytic antioxidant compounds as medical countermeasures against nuclear, radiological, and chemical weapons, as well as for diseases and disorders of the respiratory system, central nervous system, and oncology. Its lead compound includes AEOL 10150 that has completed two Phase I clinical trials, which ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1994
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: AOLS

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Aug 25, 2026

Data Sources Report a data error